Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Published on March 4, 2014 at 11:04 AM · No Comments

Beckman Coulter Life Sciences today announced an agreement with Wyatt Technology Corporation enabling collaboration on products, applications and technical development. The partnership brings together Wyatt’s expertise in protein characterization, light scattering and biophysics with Beckman Coulter’s expertise in particle counting, particle characterization and cell viability measurement.

“We are excited to be working with Wyatt Technology, as they have strong brand recognition in sectors such as biopharmaceuticals. Their products are already known by our Vi-Cell and analytical ultracentrifuge customers,” said Matt Rhyner, PhD, senior marketing manager, Beckman Coulter Life Sciences. “Partnering with Wyatt Technology, a storied company renowned for their technology and products, will help us expand our portfolio and presence in the particle market.”

The accord specifies that the companies will develop products for nanoparticle characterization to be marketed under the Beckman Coulter Life Sciences brand, and opens the door for future collaborations on product development and the sharing of business practices.

“Collaboration with Beckman Coulter has been of interest since getting to know Wallace Coulter in the late 1970s,” explained Dr. Philip Wyatt, chief executive officer, Wyatt Technology. “Entering into this agreement with a company that has the history and strong product portfolio of Beckman Coulter, we see a great opportunity to expand market access while retaining the strength and character upon which our customers rely.”

Taken together with the recent addition of the MET ONE and HIAC brands, the accord with Wyatt enables Beckman Coulter to provide a greater range of particle characterization solutions and to further enhance their world-class customer support and service.

Currently being introduced at Pittcon 2014 Booth 1964, the Multisizer 4e COULTER COUNTER is the latest Beckman Coulter innovation in particle counting and characterization, measuring particles as small as 0.2 microns.

About Beckman Coulter Particle Characterization and Counting

Beckman Coulter Particle Characterization develops, manufactures and markets products that are used to study, analyze and quantify particles of any type. The group serves customers as diverse as cell biologists and cement manufacturers. Serving particle customers since 1960, the group specializes in the Coulter Principle, laser diffraction, dynamic light scattering, zeta potential and automated cell analysis to understand all aspects of particulate samples. For more information, visit www.particle.com.

About Beckman Coulter Life Sciences

Beckman Coulter Life Sciences’ global leadership and world-class service and support delivers instrument systems, reagents and services to improve workflow and outcomes for researchers in academic and commercial life sciences laboratories, enabling discoveries in biology-based research and development, and solutions for bioprocessing. A leader in centrifugation and flow cytometry, Beckman Coulter also has brought to market innovations in capillary electrophoresis, particle characterization and laboratory automation. Its products are used to further important areas of scientific investigation, including genomics and proteomics. For more information, please visit www.beckmancoulter.com.

Beckman Coulter and the stylized logo are trademarks of Beckman Coulter, Inc. and are registered in the USPTO. The trademarks mentioned herein are the property of Beckman Coulter, or their respective owners.

Posted in: Business / Finance

Tags: , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Research findings could help explain how some people stave off dementia